19.06
0.32%
+0.06
Envista Holdings Corp stock is currently priced at $19.06, with a 24-hour trading volume of 3.00M.
It has seen a +0.32% increased in the last 24 hours and a -6.84% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $19.43 pivot point. If it approaches the $18.53 support level, significant changes may occur.
Previous Close:
$19.00
Open:
$19.19
24h Volume:
3.00M
Market Cap:
$3.28B
Revenue:
$2.57B
Net Income/Loss:
$-100.20M
P/E Ratio:
17.65
EPS:
1.08
Net Cash Flow:
$217.50M
1W Performance:
-7.57%
1M Performance:
-6.84%
6M Performance:
-10.64%
1Y Performance:
-46.07%
Envista Holdings Corp Stock (NVST) Company Profile
Name
Envista Holdings Corp
Sector
Industry
Phone
714 817 7000
Address
Building E, 200 South Kraemer Boulevard, Brea, CA
Envista Holdings Corp Stock (NVST) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-09-24 | Downgrade | Jefferies | Buy → Hold |
Feb-08-24 | Downgrade | William Blair | Outperform → Mkt Perform |
Jan-05-24 | Initiated | UBS | Neutral |
Dec-11-23 | Downgrade | Goldman | Buy → Sell |
Nov-16-23 | Initiated | Needham | Hold |
Nov-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
Aug-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
Jan-31-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Oct-26-21 | Upgrade | BofA Securities | Neutral → Buy |
Aug-05-21 | Resumed | Credit Suisse | Outperform |
Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
Jun-16-20 | Initiated | Piper Sandler | Neutral |
Dec-17-19 | Resumed | Evercore ISI | Outperform |
Oct-14-19 | Initiated | BofA/Merrill | Neutral |
Oct-14-19 | Initiated | Credit Suisse | Neutral |
Oct-14-19 | Initiated | Evercore ISI | Outperform |
Oct-14-19 | Initiated | Goldman | Buy |
Oct-14-19 | Initiated | JP Morgan | Overweight |
Oct-14-19 | Initiated | Jefferies | Buy |
Oct-14-19 | Initiated | Morgan Stanley | Equal-Weight |
Oct-14-19 | Initiated | Robert W. Baird | Outperform |
Oct-14-19 | Initiated | Stifel | Buy |
Oct-14-19 | Initiated | William Blair | Outperform |
View All
Envista Holdings Corp Stock (NVST) Latest News
Unveiling 4 Analyst Insights On Envista Holdings
Benzinga
Envista (NVST) Q1 Earnings Miss Estimates, Margins Down
Zacks Investment Research
Here's What Key Metrics Tell Us About Envista (NVST) Q1 Earnings
Zacks Investment Research
Envista (NVST) Lags Q1 Earnings and Revenue Estimates
Zacks Investment Research
Envista (NVST) Faces Macroeconomic Challenges, FX Headwind
Zacks Investment Research
Envista (NVST) Down 5.8% Since Last Earnings Report: Can It Rebound?
Zacks Investment Research
Envista Holdings Corp Stock (NVST) Financials Data
Envista Holdings Corp (NVST) Revenue 2024
NVST reported a revenue (TTM) of $2.57 billion for the quarter ending December 31, 2023, a -0.10% decline year-over-year.
Envista Holdings Corp (NVST) Net Income 2024
NVST net income (TTM) was -$100.20 million for the quarter ending December 31, 2023, a -141.22% decrease year-over-year.
Envista Holdings Corp (NVST) Cash Flow 2024
NVST recorded a free cash flow (TTM) of $217.50 million for the quarter ending December 31, 2023, a +103.27% increase year-over-year.
Envista Holdings Corp (NVST) Earnings per Share 2024
NVST earnings per share (TTM) was -$0.61 for the quarter ending December 31, 2023, a -144.53% decline year-over-year.
About Envista Holdings Corp
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures and markets dental products in the United States and internationally. The company operates in two segment, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare systems, Alpha Bio Tec, Implant Direct, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Ormco, Insignia, AOA, and Spark brands. This segment also offers software packages used for the treatment planning of dental implants and prosthetics. The company's Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, KaVo, Pelton & Crane, Kerr, MetrexTM, Sybron Endo, Total Care, and Pentron brands to dental offices, clinics, and hospitals. The company was incorporated in 2018 and is headquartered in Brea, California.
Cap:
|
Volume (24h):